Skip to content 
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | 1.46% | -0.41% |
| 1-Month Return | 11.77% | 3.64% |
| 3-Month Return | 26.29% | 2.03% |
| 6-Month Return | 24.98% | 11.05% |
| 1-Year Return | 46.13% | 18.71% |
| 3-Year Return | 43.19% | 73.04% |
| 5-Year Return | -21.9% | 71.62% |
| 10-Year Return | 81.25% | 253.1% |
| Stock name | Ticker | Weight |
|---|---|---|
 GUARDANT HEALTH INC | GH | 9.55% |
 NATERA INC | NTRA | 8.43% |
 KRYSTAL BIOTECH INC | KRYS | 5.45% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 4.47% |
 TWIST BIOSCIENCE CORP | TWST | 4.08% |
 LIGAND PHARMACEUTICALS | LGND | 3.87% |
 BRIDGEBIO PHARMA INC | BBIO | 3.54% |
 UNITED THERAPEUTICS CORP | UTHR | 3.07% |
 ELI LILLY & CO | LLY | 2.95% |
 TRAVERE THERAPEUTICS INC | TVTX | 2.94% |
 VERTEX PHARMACEUTICALS IN | VRTX | 2.8% |
 SAMSUNG BIOLOGICS CO LTD | 207940.KS | 2.6% |
 CORTEVA INC | CTVA | 2.47% |
 MEDPACE HOLDINGS INC | MEDP | 2.32% |
 REGENERON PHARMACEUTICALS | REGN | 2.22% |
 ASTRAZENECA PLC | AZN.L | 2.18% |
 TEMPUS AI INC-CL A | TEM | 1.97% |
 ARGENX SE | ARGX.BR | 1.72% |
 REPLIGEN CORP | RGEN | 1.59% |
 NEUROCRINE BIOSCIENCES IN | NBIX | 1.54% |
 CHARLES RIVER LABORATORIE | CRL | 1.52% |
 BIONTECH SE-ADR | BNTX | 1.41% |
 PRAXIS PRECISION MEDICINE | PRAX | 1.33% |
 CAREDX INC | CDNA | 1.29% |
 VERACYTE INC | VCYT | 1.22% |
 STOKE THERAPEUTICS INC | STOK | 1.21% |
 GRAIL INC | GRAL | 1.17% |
 PTC THERAPEUTICS INC | PTCT | 1.16% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 1.09% |
 INSMED INC | INSM | 1.06% |
 IQVIA HOLDINGS INC | IQV | 1.03% |
 REVOLUTION MEDICINES INC | RVMD | 1% |
 CRISPR THERAPEUTICS AG | CRSP | 0.99% |
 THERMO FISHER SCIENTIFIC | TMO | 0.88% |
 SARTORIUS AG-VORZUG | SRT3.DE | 0.86% |
 ANAPTYSBIO INC | ANAB | 0.82% |
 CADENCE DESIGN SYS INC | CDNS | 0.76% |
 BEAM THERAPEUTICS INC | BEAM | 0.75% |
 HINGE HEALTH INC-A | HNGE | 0.69% |
 FIRST TRACKS BIOTHERAPEUT | TRAX | 0.67% |
 AGILENT TECHNOLOGIES INC | A | 0.64% |
 AXSOME THERAPEUTICS INC | AXSM | 0.64% |
 DANAHER CORP | DHR | 0.61% |
 GENMAB A/S -SP ADR | GMAB | 0.53% |
 QIAGEN N.V. | QIA.DE | 0.5% |
 MODERNA INC | MRNA | 0.47% |
 CELCUITY INC | CELC | 0.47% |
 ROIVANT SCIENCES LTD | ROIV | 0.46% |
 MINERALYS THERAPEUTICS IN | MLYS | 0.43% |
 COGENT BIOSCIENCES INC | COGT | 0.42% |
 VERADERMICS INC | MANE | 0.4% |
 KINIKSA PHARMACEUTICALS I | KNSA | 0.39% |
 RHYTHM PHARMACEUTICALS IN | RYTM | 0.38% |
 ARCUTIS BIOTHERAPEUTICS I | ARQT | 0.37% |
 BRISTOL-MYERS SQUIBB CO | BMY | 0.36% |
 BIO-RAD LABORATORIES-A | BIO | 0.3% |
 BEONE MEDICINES LTD-ADR | ONC | 0.28% |
 TARSUS PHARMACEUTICALS IN | TARS | 0.27% |
 NEUROGENE INC | NGNE | 0.25% |
 ULTRAGENYX PHARMACEUTICAL | RARE | 0.24% |
 TG THERAPEUTICS INC | TGTX | 0.22% |
 LIQUIDIA CORP | LQDA | 0.2% |
 GENEDX HOLDINGS CORP | WGS | 0.17% |
 SAMSUNG EPISHOLDINGS CO L | 0126Z0.KS | 0.14% |
 ALNYLAM PHARMACEUTICALS I | ALNY | 0.1% |
 IONIS PHARMACEUTICALS INC | IONS | 0.1% |
 CASH | CASH | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 OMNIAB INC - 15.00 EARNOU | 2200964 | 0% |
 Net Current Assets | Net.Current.Assets | -0.01% |
| Sector | Weight |
|---|---|
|
Health care | 96.79% |
|
Materials | 2.44% |
|
Information Technology | 0.76% |
Franklin Genomic Advancements ETF (HELX) share price today is $43.4241.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $43.4. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $29.68.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied 
